90 Pushkin st./ 14 Aurora st., Ufa, Russia, 450008
Call Center
+7 (347) 286-5303 eye@bashgmu.ru, eye@anrb.ru
  1. History of the Institute
  2. News
  3. News: Conference
  4. Participation in the conference devoted to problems and prospects of using antimonopolization therapy. MNTK "eye microsurgery" them. Acad. S. N. Fedorov, 5 Oct 2016

Participation in the conference devoted to problems and prospects of using antimonopolization therapy. MNTK "eye microsurgery" them. Acad. S. N. Fedorov, 5 Oct 2016

4eed4984bd67f045679d171e201f84d3.JPG
8a0f8e0e60d2685eaa052b904407f3e6.JPG
965dfc5759330f44db2f25ee8fe41b59.JPG
65ddd66ed72dba027b9af8018b3219f3.JPG
7871078e06582edce91f50e774ebd6d9.JPG
10 October 2016, Monday 00:00 Просмотров: 749

October 5 in the Kaluga branch of the fgbi "IRTC "eye microsurgery" them. Acad. S. N. Fedorov" of the Ministry of health of Russia, city of Kaluga hosted a conference devoted to problems and prospects of using antimonopolization therapy. In the conference participated more than 70 ophthalmologists involved in the treatment of diseases of the Central division of the retina in age-related macular degeneration, macular edema diabeticescom.

In the framework of the conference were invited experts concerned with the treatment of diseases of the macula using antimonopolization methods:

· Budzinski Mary Viktorovna, doctor of medical Sciences, FEDERAL state scientific institution research Institute of eye diseases, Moscow.
· Faizrakhmanov Rinat Rustamovich, doctor of medical Sciences, SBD "Ufa research Institute of eye diseases of the Academy of Sciences of Belarus", Ufa.

Budzynska M. V. presented a plenary lecture on the treatment of age-related macular degeneration, focusing on etiology, pathogenesis and current therapies. During the lecture were presented the new molecule that extends the capabilities of antimonopolization therapy. Special emphasis was placed on forms of macular degeneration, difficult therapy.

Faizrakhmanov RR presented a lecture for 1.5 hours "New therapeutic approaches to the treatment of DMO", devoted to the possibilities of treatment of diabetic macular edema. During the lecture were presented the modern aspects of therapy based on laser technology, the use of steroid drugs and antimonopolization therapies. Was presented a comparative analysis of the effectiveness antimonopolization drugs based on researches VIVID and VISTA, the detailed description of clinically significant macular edema.

style="text-align: justify;"> The lecture was presented his experience with antimonopolistic drugs in the treatment of diabetic macular edema based on the dynamics of functional and morphological parameters of macular area, including the optical density of the macular pigment.

The material aroused great interest, which was underlined by discutables many issues. On the basis of the material presented and the views of experts were the drugs of first choice therapy of macular edema, which is relevant in terms of guidelines.